Cancer vaccines have long sounded like science fiction, but a new wave of nanoparticle research is pushing that idea closer to everyday reality. By packaging tumor signals into tiny, engineered ...
In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how certain immune cells can break through tumors’ defenses. They have also ...
Live Science on MSN
A fentanyl vaccine enters human trials in 2026 — here's how it works
A vaccine in development would be the first proactive treatment for overdose and fentanyl addiction, if approved. A vaccine ...
In a study published in OncoImmunology, researchers from the German Cancer Research Center and Heidelberg University have created a therapeutic vaccine that mobilizes the immune system to target ...
Morning Overview on MSN
Scientists may have built a universal cancer vaccine
Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in ...
Filoviruses get their name from the Latin word "filum," meaning thread—a reference to their long, filamentous shape. This virus family ...
A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model of late-stage metastatic disease, UT Southwestern Medical Center scientists ...
A lipid nanoparticle-based vaccine prevented tumor formation and metastasis in the majority of treated mice. Researchers from the University of Massachusetts (UMass) Amherst (MA, USA) have created a ...
An illustration of a self-assembling protein nanoparticle (SApNP) displaying Ebola virus surface proteins. This vaccine strategy is designed to help the immune system more effectively and respond to ...
A nanoparticle-based vaccine prevented melanoma, pancreatic, and breast cancers in mice, keeping up to 88% tumor-free and stopping cancer spread. (Nanowerk News) A study led by University of ...
A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast cancers in mice. The corresponding study was published in Cell Reports Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results